Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Versant Ignite is the internal drug discovery engine of Versant Ventures, designed to bridge the gap between academic research and the formation of venture-backed biotechnology companies. Operating out of specialized laboratory facilities in San Diego and Vancouver, the engine provides the infrastructure and expertise necessary to validate early-stage biological targets and develop lead therapeutic candidates. Ignite is staffed by a team of experienced drug hunters and entrepreneurs-in-residence who work closely with academic founders to conduct "killer experiments" that de-risk programs before they receive significant Series A funding. This model allows Versant to build high-conviction companies with well-defined development paths and robust intellectual property. Since its formalization, Ignite has been instrumental in launching several innovative startups across diverse therapeutic areas, including oncology, immunology, and nephrology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VVP Ignite.